Home › Companies › Treace Medical Concepts, Inc. › 2025-2026

Treace Medical Concepts, Inc. 2025-2026 Proxy Voting Records

Compiled from SEC Form N-PX filings and Treace Medical Concepts, Inc.’s Form 8-K, filed 2026-05-20 (Item 5.07 on EDGAR). Page generated 02 October 2026.

  • 5Ballot items
  • 114Asset managers
  • 634Fund votes
  • 2026-05-19Meeting date

Proxy season: 2023-2024 2024-2025 2025-2026

Explore Treace Medical Concepts, Inc. in the interactive database Compare manager voting policies

Official 2025-2026 meeting results reported by Treace Medical Concepts, Inc.

These tallies are Treace Medical Concepts, Inc.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed 2026-05-20 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.

Treace Medical Concepts, Inc. — official shareholder meeting results, meeting held 2026-05-19
Ballot itemForAgainst AbstainWithheldBroker non-votesOutcome
Elect Director: Lance A. Berry 33,804,407---- 820,72313,516,432 Majority: yes
Elect Director: Elizabeth S. Hanna 30,856,965---- 3,768,16513,516,432 Majority: yes
Elect Director: Jane E. Kiernan 33,587,226---- 1,037,90413,516,432 Majority: yes
Proposal 2: Advisory Vote on Executive Compensation 32,785,5051,724,383115,242 --13,516,432 Majority: yes
Proposal 3: Ratification of Selection of Independent Registered Public Accounting Firm 47,885,305120,733135,524 --0 Majority: yes

Source: Treace Medical Concepts, Inc., Form 8-K, filed with the SEC on 2026-05-20 — read the filing on EDGAR.

How asset managers voted at the Treace Medical Concepts, Inc. 2025-2026 meeting

Each item below shows how the 114 asset managers that disclosed a Treace Medical Concepts, Inc. vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report.

1. APPROVAL, ON AN ADVISORY, NON-BINDING BASIS, OF THE COMPENSATION OF THE COMPANY'S NAMED EXECUTIVE OFFICERS.

SECTION 14A SAY-ON-PAY VOTESMajority of the votes cast: yes

Combines 3 wordings of this item as funds reported it.

95% Majority: yes · of votes cast

FOR 95%
FOR: 32,785,505AGAINST: 1,724,383

Treace Medical Concepts, Inc.’s own tally for this item (“Proposal 2: Advisory Vote on Executive Compensation”): 32,785,505 for, 1,724,383 against, per its Form 8-K filed 2026-05-20 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 64,872,976 outstanding shares: 50.5% for, 3% against (53.2% of the company cast a for/against vote).

The 113 asset managers below cast 98% of the shares they voted on this item FOR (26,761,072 for, 531,846 against).

FOR 98%
FOR: 26,761,072 (98.0%)AGAINST: 531,846 (1.9%)ABSTAIN: 9,331 (0.0%)
Largest asset managers voting on “APPROVAL, ON AN ADVISORY, NON-BINDING BASIS, OF THE COMPENSATION OF THE COMPANY'S NAMED EXECUTIVE OFFICERS.” at Treace Medical Concepts, Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
CIBC Private Wealth Group LLC14,706,8630 00For
BlackRock2,360,0371,130 00For
Vanguard2,274,5653 00For
GEODE CAPITAL MANAGEMENT, LLC812,5350 00For
Charles Schwab707,9110 00For
State Street695,8801,082 00For
ACADIAN ASSET MANAGEMENT LLC692,8380 00For
ARMISTICE CAPITAL, LLC690,0440 00For
Fidelity660,0540 00For
STATE BOARD OF ADMINISTRATION OF FLORIDA RETIREMENT SYSTEM316,1240 00For
AQR269,3060 00For
Northern Trust1,420251,962 00Against
Citadel202,4390 00For
First Eagle Investment Management, LLC200,0000 00For
STIFEL NICOLAUS & CO INC \MO\191,2280 00For
Goldman Sachs187,0940 00For
FIRST EAGLE FUNDS174,1410 00For
Nuveen152,4340 00For
MELLON INVESTMENTS Corp148,8570 00For
Dimensional0136,285 00Against
JACOBS LEVY EQUITY MANAGEMENT, INC118,6470 00For
Equitable109,3260 00For
TIAA101,0490 00For
PARADIGM CAPITAL MANAGEMENT INC/NY100,0000 00For
QUANTITATIVE MASTER SERIES LLC73,6720 00For

Showing the 25 largest of 113 asset managers. See all 113 in the interactive database.

2. Election of Directors: Elizabeth S. Hanna

DIRECTOR ELECTIONSMajority of the votes cast: yes

Combines 6 wordings of this item as funds reported it.

89% Majority: yes · of votes cast

FOR 89%11%
FOR: 30,856,965WITHHELD: 3,768,165

Treace Medical Concepts, Inc.’s own tally for this item (“Elect Director: Elizabeth S. Hanna”): 30,856,965 for, 3,768,165 withheld, per its Form 8-K filed 2026-05-20 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 64,872,976 outstanding shares: 47.6% for, 6% withheld (53.4% of the company cast a for/withheld vote).

The 39 asset managers below cast 100% of the shares they voted on this item FOR (4,273,508 for, 0 against).

FOR 88%12%
FOR: 4,273,508 (88.2%)ABSTAIN: 573,254 (11.8%)
Largest asset managers voting on “Election of Directors: Elizabeth S. Hanna” at Treace Medical Concepts, Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Vanguard1,900,7540 5,8720For
BlackRock947,3830 00For
Fidelity646,9980 1,9000For
Charles Schwab353,8050 00For
FIRST EAGLE FUNDS00 174,1410Abstain
Equitable70,0860 39,2400For
TIAA101,0490 00For
Dimensional00 73,6800Abstain
QUANTITATIVE MASTER SERIES LLC73,6720 00For
CLEARWATER INVESTMENT TRUST00 68,6420Abstain
BRIDGEWAY FUNDS INC00 50,0000Abstain
PACE SELECT ADVISORS TRUST00 40,8140Abstain
Goldman Sachs39,0040 00For
Lincoln Financial36,2000 00For
Northern Trust00 25,8300Abstain
AIG/SunAmerica00 24,5030Abstain
Global X23,0700 00For
MASTER INVESTMENT PORTFOLIO19,2390 00For
Pacific Life18,3310 00For
John Hancock00 16,1850Abstain
Nationwide13,8390 00For
Bridge Builder Trust9,4980 00For
Brighthouse00 9,3310Abstain
ProShares00 7,9120Abstain
DWS00 7,3380Abstain

Showing the 25 largest of 39 asset managers. See all 39 in the interactive database.

3. Election of Directors: Jane E. Kiernan

DIRECTOR ELECTIONSMajority of the votes cast: yes

Combines 6 wordings of this item as funds reported it.

97% Majority: yes · of votes cast

FOR 97%
FOR: 33,587,226WITHHELD: 1,037,904

Treace Medical Concepts, Inc.’s own tally for this item (“Elect Director: Jane E. Kiernan”): 33,587,226 for, 1,037,904 withheld, per its Form 8-K filed 2026-05-20 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 64,872,976 outstanding shares: 51.8% for, 2% withheld (53.4% of the company cast a for/withheld vote).

The 39 asset managers below cast 100% of the shares they voted on this item FOR (4,712,000 for, 0 against).

FOR 97%
FOR: 4,712,000 (97.2%)ABSTAIN: 134,763 (2.8%)
Largest asset managers voting on “Election of Directors: Jane E. Kiernan” at Treace Medical Concepts, Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Vanguard1,902,6470 3,9800For
BlackRock947,3830 00For
Fidelity648,8980 00For
Charles Schwab353,8050 00For
FIRST EAGLE FUNDS174,1410 00For
Equitable70,0860 39,2400For
TIAA101,0490 00For
Dimensional00 73,6800Abstain
QUANTITATIVE MASTER SERIES LLC73,6720 00For
CLEARWATER INVESTMENT TRUST68,6420 00For
BRIDGEWAY FUNDS INC50,0000 00For
PACE SELECT ADVISORS TRUST40,8140 00For
Goldman Sachs39,0040 00For
Lincoln Financial36,2000 00For
Northern Trust25,8300 00For
AIG/SunAmerica24,5030 00For
Global X23,0700 00For
MASTER INVESTMENT PORTFOLIO19,2390 00For
Pacific Life18,3310 00For
John Hancock16,1850 00For
Nationwide13,8390 00For
Bridge Builder Trust9,4980 00For
Brighthouse00 9,3310Abstain
ProShares7,9120 00For
DWS7,3380 00For

Showing the 25 largest of 39 asset managers. See all 39 in the interactive database.

4. Election of Directors: Lance A. Berry

DIRECTOR ELECTIONSMajority of the votes cast: yes

Combines 6 wordings of this item as funds reported it.

98% Majority: yes · of votes cast

FOR 98%
FOR: 33,804,407WITHHELD: 820,723

Treace Medical Concepts, Inc.’s own tally for this item (“Elect Director: Lance A. Berry”): 33,804,407 for, 820,723 withheld, per its Form 8-K filed 2026-05-20 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 64,872,976 outstanding shares: 52.1% for, 1% withheld (53.4% of the company cast a for/withheld vote).

The 39 asset managers below cast 100% of the shares they voted on this item FOR (4,712,002 for, 0 against).

FOR 97%
FOR: 4,712,002 (97.2%)ABSTAIN: 134,761 (2.8%)
Largest asset managers voting on “Election of Directors: Lance A. Berry” at Treace Medical Concepts, Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Vanguard1,902,6490 3,9780For
BlackRock947,3830 00For
Fidelity648,8980 00For
Charles Schwab353,8050 00For
FIRST EAGLE FUNDS174,1410 00For
Equitable70,0860 39,2400For
TIAA101,0490 00For
Dimensional00 73,6800Abstain
QUANTITATIVE MASTER SERIES LLC73,6720 00For
CLEARWATER INVESTMENT TRUST68,6420 00For
BRIDGEWAY FUNDS INC50,0000 00For
PACE SELECT ADVISORS TRUST40,8140 00For
Goldman Sachs39,0040 00For
Lincoln Financial36,2000 00For
Northern Trust25,8300 00For
AIG/SunAmerica24,5030 00For
Global X23,0700 00For
MASTER INVESTMENT PORTFOLIO19,2390 00For
Pacific Life18,3310 00For
John Hancock16,1850 00For
Nationwide13,8390 00For
Bridge Builder Trust9,4980 00For
Brighthouse00 9,3310Abstain
ProShares7,9120 00For
DWS7,3380 00For

Showing the 25 largest of 39 asset managers. See all 39 in the interactive database.

5. Ratification of the appointment of Grant Thornton LLP as the Company's independent registered public accounting firm for the year ending December 31, 2026.

AUDIT-RELATEDMajority of the votes cast: yes

Combines 3 wordings of this item as funds reported it.

99.7% Majority: yes · of votes cast

FOR 99.7%
FOR: 47,885,305AGAINST: 120,733

Treace Medical Concepts, Inc.’s own tally for this item (“Proposal 3: Ratification of Selection of Independent Registered Public Accounting Firm”): 47,885,305 for, 120,733 against, per its Form 8-K filed 2026-05-20 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 64,872,976 outstanding shares: 74% for, 0.2% against (74% of the company cast a for/against vote).

The 38 asset managers below cast 100% of the shares they voted on this item FOR (4,768,789 for, 0 against).

FOR 99.8%
FOR: 4,768,789 (99.8%)ABSTAIN: 9,331 (0.2%)
Largest asset managers voting on “Ratification of the appointment of Grant Thornton LLP as the Company's independent registered public accountin” at Treace Medical Concepts, Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Vanguard1,906,6260 00For
BlackRock947,3830 00For
Fidelity648,8980 00For
Charles Schwab353,8050 00For
FIRST EAGLE FUNDS174,1410 00For
Equitable109,3260 00For
TIAA101,0490 00For
Dimensional73,6800 00For
QUANTITATIVE MASTER SERIES LLC73,6720 00For
BRIDGEWAY FUNDS INC50,0000 00For
PACE SELECT ADVISORS TRUST40,8140 00For
Goldman Sachs39,0040 00For
Lincoln Financial36,2000 00For
Northern Trust25,8300 00For
AIG/SunAmerica24,5030 00For
Global X23,0700 00For
MASTER INVESTMENT PORTFOLIO19,2390 00For
Pacific Life18,3310 00For
John Hancock16,1850 00For
Nationwide13,8390 00For
Bridge Builder Trust9,4980 00For
Brighthouse00 9,3310Abstain
ProShares7,9120 00For
DWS7,3380 00For
SEI6,2000 00For

Showing the 25 largest of 38 asset managers. See all 38 in the interactive database.

Largest Treace Medical Concepts, Inc. shareholders voting in 2025-2026

Ranked by the number of Treace Medical Concepts, Inc. shares each manager voted on the most widely held ballot item of the 2025-2026 meeting, shown as a share of the 64,872,976 shares outstanding at the time of that meeting.

Top Treace Medical Concepts, Inc. shareholders by shares voted, 2025-2026
#Asset manager % of shares outstanding
1CIBC Private Wealth Group LLC 22.67%
2BlackRock 3.64%
3Vanguard 3.51%
4GEODE CAPITAL MANAGEMENT, LLC 1.25%
5Charles Schwab 1.09%
6State Street 1.07%
7ACADIAN ASSET MANAGEMENT LLC 1.07%
8ARMISTICE CAPITAL, LLC 1.06%
9Fidelity 1.02%
10STATE BOARD OF ADMINISTRATION OF FLORIDA RETIREMENT SYSTEM 0.49%

Reported Treace Medical Concepts, Inc. ownership

Positions disclosed to the SEC on Schedules 13D and 13G, Form 13F and the company’s own proxy statement (DEF 14A).

Treace Medical Concepts, Inc. beneficial owners on record for the 2025-2026 proxy season
Holder % outstanding Disclosure
John T. Treace 19.32% 13G
Neil Gagnon 9.47% 13G
BANK OF AMERICA CORP /DE/ 5.45% 13G
BlackRock 5.15% 13F
Vanguard Group 3.50% 13F
State Street 1.90% 13F
Millennium Management 1.77% 13F
Geode Capital 1.56% 13F
D.E. Shaw 1.30% 13F
Citadel Advisors 1.27% 13F

Percentages above are of 64,872,976 shares outstanding, as reported by Treace Medical Concepts, Inc. on its Form 10-Q dated 2026-04-30 (see the filing on EDGAR). This is the count contemporaneous with the 2025-2026 meeting, so the percentages are the ones that were true then, not ones restated against today’s share count.

About this page

Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered investment companies and institutional managers disclose how they voted every proxy, and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from Treace Medical Concepts, Inc.’s 10-Q dated 2026-04-30. This page is a static snapshot rebuilt weekly on 02 October 2026; a live search always shows the current data.

At Treace Medical Concepts, Inc.'s shareholder meeting held 2026-05-19, in the 2025-2026 proxy season, 114 asset managers reported how they voted on 5 ballot items in their SEC Form N-PX filings, covering 634 separate fund positions. On the most widely held item on that ballot — APPROVAL, ON AN ADVISORY, NON-BINDING BASIS, OF THE COMPENSATION OF THE COMPANY'S NAMED… — FOR was 95% of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side), which is more than half. Whether the item was approved is for the filing to say; that statement has not been read for this item. Source: Treace Medical Concepts, Inc.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on 2026-05-20.

Treace Medical Concepts, Inc. proxy season coverage: 2023-2024 · 2024-2025 · 2025-2026 (this page).